The “Big Five” Canadian banks offer investment funds and include Royal Bank of Canada, Toronto Dominion Bank (TD Canada Trust), Bank of Nova Scotia, Bank of Montreal and Canadian Imperial Bank of Commerce (CIBC). Let’s explore the best place for you to invest.
Latest News
At the open: Dow nears 20,000, Nasdaq hits record + MORE Dec 27th
Apple top stock on all three indexes; Biogen up after FDA clears muscular atrophy drug
.... More »
Canadian home sales expected to fall 11% this year + MORE Jun 15th
Home sales in Canada are projected to slide by 11 per cent this year, according to a new forecast by a national real estate group..... More »
Trump Organization CFO Allen Weisselberg reportedly granted immunity - CBC.ca Aug 25th
CBC.caTrump Organization CFO Allen Weisselberg reportedly granted immunityCBC.caFederal prosecutors have granted immunity to the Trump Organization's chief financial officer in an investigation involving U.S. President Donald Trump's former personal lawyer, Michael Cohen, the Wall Street J.... More »
5 personal finance myths you probably still believe + MORE Jul 24th
I get a kick out of the television series Mythbusters. For those of you unfamiliar with the program, each week the show’s stars, Jamie and Adam, try to prove or disprove (busted!) popular myths, adages and urban legends. I mean, how can you not like a show that answers such important questions as .... More »
Variable mortgage rates regaining traction as Bank of Canada cuts rates + MORE Sep 5th
The decision by the Bank of Canada to cut its key interest rate target this week was good news for borrowers with variable-rate mortgages, bringing back some of the shine for the once popular loans.
The rate cut prompted big commercial banks to lower their prime rates, which are used to set the r.... More »
Why Main Street may beat out Wall Street, a soaring airline stock, and why pot stocks are flying high
– theglobeandmail.com
A roundup of investment ideas for active investors
Canada Goose prepares for IPO: sources
– theglobeandmail.com
IPO would demonstrate the explosive growth the company has experienced
Two small boys balance themselves on the rail of a border fence during an event organized by the Border Network for Human Rights, on the outskirts of Ciudad Juarez, Mexico, Monday, Feb. 15, 2016. (Ivan Pierre Aguirre/AP)Oct. 7, 2016: Hillary Clinton has taken some time of the campaign trail to prepare for this Sunday’s second presidential debate, but her team hasn’t stopped arguing over hurricane politics in Florida. Donald Trump, meanwhile, found a new conspiracy theory—border-jumping, voting illegal immigrants—as his stock fell even further in the polls. What won’t help is a newly unveiled video from 2005 where he has some pretty crass things to say about women.
Here’s our daily U.S. election Bulldog, rounding up what you need to know about what happened on this day on the campaign trail.
A new Trump conspiracy theory
Remember several weeks ago when Trump was losing big in the polls and he suggested the election was going to be rigged? He added another layer to that conspiracy theory on Friday, after a member of the National Border Patrol Council—a union group that endorsed Trump earlier this year—claimed that agents have been instructed not to deport illegal immigrants so they can cast their vote in November…
Mylan to pay $465M settlement over Medicaid EpiPen rebates
– canadianbusiness.com
NEW YORK, N.Y. – Mylan will pay $465 million to settle allegations that it overbilled Medicaid for its life-saving EpiPen allergy injection.
The federal government says EpiPen is a branded drug, which means Mylan should have been paying it a far higher rebate under the government’s complex pricing rules.
Mylan said Friday the proposed settlement resolves all potential federal and state government claims. It also finds no wrongdoing on the part of the England-based company.
Mylan also lowered its 2016 guidance for earnings per share in part because of the upcoming launch of generic EpiPens. Its new range is for $4.70 to $4.90 per share, which is below the average analyst estimate of $4.95 per share compiled by FactSet.
Shares of the company jumped more than 9 per cent in after-hours trading.
The post Mylan to pay $465M settlement over Medicaid EpiPen rebates appeared first on Canadian Business – Your Source For Business News.
The federal government says EpiPen is a branded drug, which means Mylan should have been paying it a far higher rebate under the government’s complex pricing rules.
Mylan said Friday the proposed settlement resolves all potential federal and state government claims. It also finds no wrongdoing on the part of the England-based company.
Mylan also lowered its 2016 guidance for earnings per share in part because of the upcoming launch of generic EpiPens. Its new range is for $4.70 to $4.90 per share, which is below the average analyst estimate of $4.95 per share compiled by FactSet.
Shares of the company jumped more than 9 per cent in after-hours trading.
The post Mylan to pay $465M settlement over Medicaid EpiPen rebates appeared first on Canadian Business – Your Source For Business News.
'Asset recycling’ must prioritize public good
– theglobeandmail.com
Privatization of legacy public assets to raise funds for new infrastructure could provide investment opportunities. But the greater public good must be the top consideration
